Beyond skin brightening, glutathione is a powerhouse for detoxification
"The Dangers of Compounded Semaglutide: The Effect." January 2025
Many people on weight loss medications experience little to no side effects
A Medicare GLP-1 Bridge program is reported to begin in July 2026, giving eligible Part D members access to weight-loss medications like Zepbound for a $50 copay per 30-day supply
However, compounded semaglutide is not FDA-approved, is prepared by a compounding pharmacy rather than a commercial manufacturer, and may differ in formulation, concentration, or inactive ingredients
These findings prompted further investigation into the synthetic version of the peptide, now known as Epithalon, to better understand its mechanisms of action and potential applications in human health